908 Devices (MASS) Share-based Compensation Growth (3y) (2023 - 2026)
908 Devices (MASS) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.45 Bn | 175.15 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 128.93 Bn | 126.05 Bn | 3.81 Bn | 23.38% |
| 3 | Medtronic | 108.03 Bn | 98.81 Bn | 6.41 Bn | 8.20% |
| 4 | Boston Scientific | 68.19 Bn | 66.74 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 48.22 Bn | 44.55 Bn | 1.29 Bn | 5.29% |
| 6 | Dexcom | 28.24 Bn | 27.13 Bn | 750.30 Mn | 0.56% |
| 7 | GE HealthCare Technologies | 27.99 Bn | 25.70 Bn | 1.98 Bn | 13.40% |
| 8 | Smith & Nephew | 27.01 Bn | 26.43 Bn | - | - |
| 9 | Koninklijke Philips | 23.72 Bn | 20.60 Bn | 2.07 Bn | - |
| 10 | 908 Devices | 260.49 Mn | 148.75 Mn | 6.88 Mn | 76.95% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 76.95% |
| Dec 31, 2025 | 9.36% |
| Sep 30, 2025 | 69.29% |
| Jun 30, 2025 | 7.24% |
| Mar 31, 2025 | 19.87% |
| Dec 31, 2024 | -37.13% |
| Sep 30, 2024 | 41.55% |
| Jun 30, 2024 | 66.72% |
| Mar 31, 2024 | 75.71% |
| Dec 31, 2023 | 96.77% |
| Sep 30, 2023 | 219.38% |
| Jun 30, 2023 | 234.31% |
| Mar 31, 2023 | 220.16% |